VC
Vivo Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-350,000
| Closed | -$16.4M | – | 43 |
|
2024
Q1 | $16.4M | Hold |
350,000
| – | – | 1.29% | 18 |
|
2023
Q4 | $12.5M | Hold |
350,000
| – | – | 1.02% | 20 |
|
2023
Q3 | $10.4M | Buy |
+350,000
| New | +$10.4M | 1.14% | 24 |
|
2021
Q4 | – | Sell |
-517,280
| Closed | -$10.9M | – | 59 |
|
2021
Q3 | $10.9M | Sell |
517,280
-1,235,066
| -70% | -$26M | 0.49% | 36 |
|
2021
Q2 | $33M | Sell |
1,752,346
-461,792
| -21% | -$8.7M | 1.43% | 18 |
|
2021
Q1 | $33.8M | Sell |
2,214,138
-121,751
| -5% | -$1.86M | 1.19% | 19 |
|
2020
Q4 | $33M | Buy |
2,335,889
+72,119
| +3% | +$1.02M | 1.47% | 14 |
|
2020
Q3 | $35.5M | Sell |
2,263,770
-52,858
| -2% | -$828K | 2.05% | 10 |
|
2020
Q2 | $40.6M | Sell |
2,316,628
-1,004,173
| -30% | -$17.6M | 2.91% | 7 |
|
2020
Q1 | $48.8M | Buy |
+3,320,801
| New | +$48.8M | 4.42% | 5 |
|
2019
Q3 | – | Sell |
-3,375,169
| Closed | -$84.4M | – | 13 |
|
2019
Q2 | $84.4M | Hold |
3,375,169
| – | – | 7.91% | 2 |
|
2019
Q1 | $76.8M | Sell |
3,375,169
-417,000
| -11% | -$9.49M | 7.66% | 2 |
|
2018
Q4 | $114M | Hold |
3,792,169
| – | – | 14.52% | 2 |
|
2018
Q3 | $109M | Buy |
+3,792,169
| New | +$109M | 10.95% | 2 |
|